Trailing-twelve-month (TTM) revenue is $82.10 Billion with a year-over-year growth of (0.84%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $20,372,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $18,556,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $20,490,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $22,681,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $82,099,000,000 |
Current P/S: $39,684,339,380 market capitalization ÷ $82,099,000,000 TTM revenue = 0.48x.
Market capitalization source: FMP quote. Quote observed 2026-09-22T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $22.68B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T08:00:42.168Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Ag Services and Oilseeds | $55.7B | $70.5B | $83.7B | $77.5B | $66.5B | $61.6B |
| Carbohydrate Solutions | $9.4B | $12.7B | $16.3B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| BRAZIL | $2.4B | $3.2B | $4.0B | $3.4B | $3.4B | $3.4B |
| CANADA | N/A | N/A | $2.3B | $2.4B |
$82.10B
$82.10 Billion
(0.84%)
vs. $82.79B a year ago (TTM)
+1.85%
5 Year compound annual growth rate
1 Year
(0.84%)
3 Year
(6.33%)
5 Year
+1.85%
10 Year
+2.68%
15 Year
(0.30%)
20 Year
+4.12%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $80.27B | ($5.26B) | (6.15%) |
| 2024 | $85.53B | ($8.40B) | (8.95%) |
| 2023 | $93.94B | ($7.62B) | (7.50%) |
| 2022 | $101.56B | +$16.31B | +19.13% |
| 2021 | $85.25B | +$20.89B | +32.47% |
| 2020 |
TTM Growth
(0.84%)
3-Year CAGR
(6.33%)
5-Year CAGR
+1.85%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T08:00:42.168Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $11.2B |
| $10.7B |
| Nutrition | $6.0B | $6.9B | $7.8B | $7.5B | $7.3B | $7.5B |
|---|
| Other Segments | $367M | $380M | $396M | $424M | N/A | N/A |
|---|
| $2.1B |
| $1.8B |
| CAYMAN ISLANDS | $4.0B | $5.5B | $5.9B | $7.6B | $5.6B | $6.1B |
|---|
| GERMANY | $2.0B | N/A | N/A | N/A | N/A | N/A |
|---|
| MEXICO | $2.2B | $2.9B | $3.7B | $3.2B | $3.2B | $2.7B |
|---|
| Other Foreign | $14.0B | $17.9B | $18.4B | $16.4B | $15.7B | $15.2B |
|---|
| SWITZERLAND | $13.8B | $18.5B | $21.8B | $19.9B | $19.9B | $17.8B |
|---|
| UNITED KINGDOM | N/A | $1.8B | $2.2B | $2.2B | $2.2B | $2.1B |
|---|
| UNITED STATES | $26.0B | $35.4B | $43.3B | $38.8B | $33.5B | $31.2B |
|---|
| $64.36B |
| ($301.00M) |
| (0.47%) |
| 2019 | $64.66B | +$315.00M | +0.49% |
| 2018 | $64.34B | +$3.51B | +5.78% |
| 2017 | $60.83B | ($1.52B) | (2.43%) |
| 2016 | $62.35B | ($5.36B) | (7.91%) |
